Amyl therapeutics is developing a breakthrough platform of fusion proteins for the treatment of amyloid mediated diseases, ie amyloidosis and neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. www.amyltx.com
Founded in 2019 by 3 prestigious scientists, AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases. The AbolerIS team is composed of scientific founders with decades of experience in basic and translational immunology and a strong leadership team with…
AEC Partners provides consulting & transactional services to the evolving Life Sciences industry : Bringing a forward-looking vision based on well-founded recommendations Facilitating senior management decision-making Mobilizing teams for business transformation Website